| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 201 | 2024 | 12628 | 4.670 |
Why?
|
| Finland | 112 | 2024 | 603 | 3.810 |
Why?
|
| Genetic Predisposition to Disease | 171 | 2024 | 17790 | 3.730 |
Why?
|
| Polymorphism, Single Nucleotide | 178 | 2024 | 15790 | 3.250 |
Why?
|
| Migraine Disorders | 30 | 2022 | 1693 | 2.560 |
Why?
|
| Genetic Loci | 42 | 2024 | 2618 | 2.170 |
Why?
|
| Multifactorial Inheritance | 31 | 2024 | 1365 | 2.120 |
Why?
|
| Genetic Variation | 55 | 2024 | 6552 | 2.110 |
Why?
|
| Migraine with Aura | 14 | 2022 | 203 | 1.870 |
Why?
|
| Gene Frequency | 42 | 2024 | 3613 | 1.630 |
Why?
|
| DNA Copy Number Variations | 19 | 2023 | 2013 | 1.600 |
Why?
|
| Schizophrenia | 28 | 2024 | 6915 | 1.520 |
Why?
|
| Genetic Association Studies | 29 | 2021 | 2716 | 1.390 |
Why?
|
| Migraine without Aura | 7 | 2018 | 82 | 1.360 |
Why?
|
| Quantitative Trait Loci | 31 | 2024 | 2101 | 1.330 |
Why?
|
| Biological Specimen Banks | 14 | 2024 | 784 | 1.280 |
Why?
|
| Chromosome Mapping | 55 | 2019 | 4626 | 1.250 |
Why?
|
| Disease | 7 | 2023 | 671 | 1.150 |
Why?
|
| Phenotype | 73 | 2024 | 16548 | 1.060 |
Why?
|
| Genome, Human | 27 | 2021 | 4418 | 1.040 |
Why?
|
| Genotype | 77 | 2024 | 12957 | 1.000 |
Why?
|
| In Situ Hybridization, Fluorescence | 23 | 2001 | 2505 | 0.910 |
Why?
|
| Factor XIII | 7 | 1999 | 59 | 0.870 |
Why?
|
| Alleles | 47 | 2024 | 6900 | 0.860 |
Why?
|
| Haplotypes | 34 | 2023 | 2764 | 0.850 |
Why?
|
| Genetic Markers | 25 | 2020 | 2609 | 0.840 |
Why?
|
| Humans | 497 | 2024 | 760613 | 0.800 |
Why?
|
| Puberty | 5 | 2024 | 498 | 0.790 |
Why?
|
| Pharyngeal Diseases | 1 | 2023 | 134 | 0.780 |
Why?
|
| Otosclerosis | 1 | 2023 | 113 | 0.780 |
Why?
|
| Menarche | 6 | 2024 | 529 | 0.780 |
Why?
|
| Genetics, Population | 20 | 2024 | 929 | 0.760 |
Why?
|
| Mutation | 44 | 2022 | 29957 | 0.750 |
Why?
|
| Cluster Headache | 1 | 2021 | 54 | 0.740 |
Why?
|
| Mutation, Missense | 16 | 2024 | 2567 | 0.730 |
Why?
|
| Body Height | 10 | 2017 | 1570 | 0.730 |
Why?
|
| Point Mutation | 17 | 2014 | 1594 | 0.720 |
Why?
|
| Genomics | 15 | 2023 | 5795 | 0.700 |
Why?
|
| Factor XIII Deficiency | 5 | 1997 | 16 | 0.680 |
Why?
|
| Respiration Disorders | 1 | 2023 | 368 | 0.670 |
Why?
|
| Lod Score | 15 | 2012 | 602 | 0.660 |
Why?
|
| Epilepsy | 17 | 2024 | 3267 | 0.660 |
Why?
|
| Psychotic Disorders | 6 | 2024 | 3193 | 0.610 |
Why?
|
| Gelsolin | 3 | 2003 | 189 | 0.600 |
Why?
|
| Sequence Analysis, DNA | 22 | 2021 | 4716 | 0.600 |
Why?
|
| Female | 263 | 2024 | 391246 | 0.590 |
Why?
|
| Founder Effect | 7 | 2023 | 186 | 0.590 |
Why?
|
| Male | 255 | 2024 | 359718 | 0.590 |
Why?
|
| Epilepsy, Generalized | 4 | 2024 | 178 | 0.580 |
Why?
|
| DiGeorge Syndrome | 2 | 2022 | 185 | 0.570 |
Why?
|
| Mendelian Randomization Analysis | 11 | 2024 | 998 | 0.570 |
Why?
|
| Pedigree | 41 | 2019 | 4578 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 4 | 8 | 2011 | 377 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 1 | 11 | 2017 | 635 | 0.550 |
Why?
|
| Databases, Genetic | 13 | 2024 | 1738 | 0.550 |
Why?
|
| Genetic Heterogeneity | 5 | 2016 | 724 | 0.550 |
Why?
|
| Genetic Pleiotropy | 6 | 2021 | 181 | 0.540 |
Why?
|
| Quantitative Trait, Heritable | 11 | 2020 | 540 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 2 | 10 | 2015 | 313 | 0.540 |
Why?
|
| Adiposity | 7 | 2024 | 1858 | 0.520 |
Why?
|
| Personality | 7 | 2015 | 552 | 0.510 |
Why?
|
| Intracranial Aneurysm | 8 | 2014 | 1276 | 0.500 |
Why?
|
| Case-Control Studies | 50 | 2024 | 22052 | 0.500 |
Why?
|
| Genetic Linkage | 24 | 2013 | 2381 | 0.500 |
Why?
|
| Population | 5 | 2020 | 140 | 0.490 |
Why?
|
| Middle Aged | 152 | 2024 | 220359 | 0.480 |
Why?
|
| Bipolar Disorder | 8 | 2023 | 5078 | 0.480 |
Why?
|
| Polymorphism, Genetic | 27 | 2018 | 4286 | 0.460 |
Why?
|
| Exons | 16 | 2016 | 2389 | 0.460 |
Why?
|
| Metabolic Diseases | 3 | 2020 | 685 | 0.460 |
Why?
|
| Membrane Proteins | 18 | 2024 | 7850 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2012 | 276 | 0.460 |
Why?
|
| Chromosomes, Human, X | 3 | 2024 | 321 | 0.450 |
Why?
|
| Nootropic Agents | 3 | 2021 | 157 | 0.450 |
Why?
|
| Ki-67 Antigen | 4 | 2003 | 631 | 0.450 |
Why?
|
| Cohort Studies | 58 | 2024 | 41337 | 0.450 |
Why?
|
| Adult | 152 | 2024 | 220007 | 0.450 |
Why?
|
| Casein Kinase Idelta | 1 | 2013 | 14 | 0.440 |
Why?
|
| Linkage Disequilibrium | 23 | 2020 | 1996 | 0.440 |
Why?
|
| Heterozygote | 17 | 2024 | 2798 | 0.440 |
Why?
|
| Open Reading Frames | 4 | 2018 | 814 | 0.430 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2013 | 108 | 0.430 |
Why?
|
| Cognition | 18 | 2024 | 6964 | 0.430 |
Why?
|
| Personal Health Services | 1 | 2012 | 24 | 0.430 |
Why?
|
| Genetics, Medical | 2 | 2015 | 336 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 8 | 7 | 2011 | 452 | 0.420 |
Why?
|
| Coronary Artery Disease | 13 | 2023 | 6659 | 0.420 |
Why?
|
| Myoclonic Epilepsies, Progressive | 3 | 2021 | 13 | 0.420 |
Why?
|
| Growth | 2 | 2015 | 365 | 0.410 |
Why?
|
| Premature Birth | 8 | 2023 | 1770 | 0.410 |
Why?
|
| Lipids | 10 | 2021 | 3336 | 0.400 |
Why?
|
| Cardiovascular Diseases | 16 | 2024 | 15760 | 0.400 |
Why?
|
| Human Genome Project | 3 | 2019 | 199 | 0.400 |
Why?
|
| Growth and Development | 1 | 2012 | 47 | 0.400 |
Why?
|
| Hydrocephalus | 1 | 2018 | 763 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2019 | 601 | 0.390 |
Why?
|
| Triglycerides | 14 | 2021 | 2476 | 0.390 |
Why?
|
| Collagen | 17 | 2022 | 2636 | 0.380 |
Why?
|
| Glaucoma, Open-Angle | 3 | 2023 | 734 | 0.370 |
Why?
|
| Genes | 6 | 2008 | 1845 | 0.370 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 884 | 0.370 |
Why?
|
| Cognition Disorders | 6 | 2019 | 3976 | 0.360 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1493 | 0.360 |
Why?
|
| Awards and Prizes | 1 | 2015 | 359 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2016 | 363 | 0.360 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1902 | 0.360 |
Why?
|
| Receptors, GABA-A | 3 | 2018 | 621 | 0.360 |
Why?
|
| Lipoproteins, VLDL | 2 | 2021 | 201 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2017 | 430 | 0.350 |
Why?
|
| Risk Factors | 60 | 2024 | 74333 | 0.350 |
Why?
|
| Educational Status | 4 | 2021 | 2514 | 0.350 |
Why?
|
| CRADD Signaling Adaptor Protein | 2 | 2019 | 6 | 0.330 |
Why?
|
| Genes, Recessive | 5 | 2023 | 626 | 0.330 |
Why?
|
| Body Mass Index | 21 | 2024 | 12914 | 0.330 |
Why?
|
| Abnormalities, Multiple | 4 | 2019 | 1415 | 0.330 |
Why?
|
| Multigene Family | 6 | 2020 | 1077 | 0.330 |
Why?
|
| Estonia | 5 | 2023 | 54 | 0.330 |
Why?
|
| Aged | 90 | 2024 | 169143 | 0.320 |
Why?
|
| Leukocytes | 7 | 2024 | 2027 | 0.320 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2015 | 3774 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2005 | 419 | 0.320 |
Why?
|
| Multiple Sclerosis | 11 | 2011 | 3204 | 0.310 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2024 | 1860 | 0.310 |
Why?
|
| Homozygote | 11 | 2022 | 1788 | 0.300 |
Why?
|
| Cadherins | 3 | 2014 | 898 | 0.300 |
Why?
|
| Asthma | 4 | 2023 | 6172 | 0.300 |
Why?
|
| Apolipoproteins B | 8 | 2022 | 388 | 0.300 |
Why?
|
| Cholesterol, HDL | 8 | 2019 | 1817 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 19 | 5 | 2010 | 347 | 0.300 |
Why?
|
| Glaucoma | 3 | 2023 | 1182 | 0.300 |
Why?
|
| Factor V | 3 | 2024 | 168 | 0.290 |
Why?
|
| Leukemia | 6 | 2024 | 1523 | 0.290 |
Why?
|
| Genetic Testing | 13 | 2018 | 3531 | 0.290 |
Why?
|
| Meta-Analysis as Topic | 8 | 2023 | 1376 | 0.290 |
Why?
|
| Models, Genetic | 12 | 2024 | 3442 | 0.290 |
Why?
|
| Proteins | 10 | 2022 | 6029 | 0.290 |
Why?
|
| Internet | 3 | 2017 | 3078 | 0.290 |
Why?
|
| Ion Transport | 1 | 2008 | 318 | 0.290 |
Why?
|
| Gene Duplication | 2 | 2008 | 314 | 0.290 |
Why?
|
| Apolipoprotein E4 | 2 | 2023 | 709 | 0.280 |
Why?
|
| Microsatellite Repeats | 12 | 2014 | 786 | 0.280 |
Why?
|
| Fibrinogen | 3 | 2015 | 887 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2024 | 12289 | 0.280 |
Why?
|
| Headache Disorders | 2 | 2021 | 148 | 0.280 |
Why?
|
| Genes, myc | 3 | 1997 | 395 | 0.270 |
Why?
|
| DNA Methylation | 6 | 2021 | 4372 | 0.270 |
Why?
|
| Adolescent | 57 | 2024 | 87809 | 0.270 |
Why?
|
| Antipsychotic Agents | 3 | 2024 | 3061 | 0.270 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 4 | 2018 | 477 | 0.270 |
Why?
|
| Peptide Elongation Factors | 2 | 2017 | 62 | 0.270 |
Why?
|
| Body Size | 4 | 2017 | 462 | 0.260 |
Why?
|
| Macular Degeneration | 2 | 2023 | 1002 | 0.260 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2003 | 800 | 0.260 |
Why?
|
| Computational Biology | 9 | 2020 | 3505 | 0.260 |
Why?
|
| Europe | 16 | 2019 | 3441 | 0.260 |
Why?
|
| Geography | 5 | 2019 | 661 | 0.260 |
Why?
|
| Calcium Channels | 5 | 2018 | 619 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2016 | 375 | 0.260 |
Why?
|
| RNA, Messenger | 21 | 2022 | 12762 | 0.250 |
Why?
|
| Molecular Sequence Data | 39 | 2014 | 17624 | 0.250 |
Why?
|
| Hyperlipidemias | 3 | 2020 | 782 | 0.250 |
Why?
|
| Thyrotropin | 3 | 2020 | 832 | 0.240 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2014 | 1032 | 0.240 |
Why?
|
| Waist-Hip Ratio | 6 | 2019 | 516 | 0.240 |
Why?
|
| Annexins | 1 | 2024 | 39 | 0.240 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 9591 | 0.240 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2003 | 217 | 0.240 |
Why?
|
| Ileus | 1 | 2024 | 57 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 7 | 4 | 2017 | 311 | 0.240 |
Why?
|
| Antisocial Personality Disorder | 2 | 2016 | 224 | 0.240 |
Why?
|
| DNA | 22 | 2024 | 7233 | 0.240 |
Why?
|
| Registries | 9 | 2024 | 8458 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 11 | 7 | 2017 | 410 | 0.230 |
Why?
|
| HLA Antigens | 6 | 2016 | 1368 | 0.230 |
Why?
|
| Ankyrins | 1 | 2024 | 123 | 0.230 |
Why?
|
| Ribonucleoproteins | 3 | 2017 | 372 | 0.230 |
Why?
|
| Young Adult | 40 | 2024 | 58748 | 0.230 |
Why?
|
| Base Sequence | 31 | 2017 | 12444 | 0.230 |
Why?
|
| Chromosomes, Human | 4 | 2011 | 442 | 0.230 |
Why?
|
| Aging | 6 | 2024 | 8652 | 0.230 |
Why?
|
| Mental Disorders | 7 | 2019 | 6796 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 9 | 7 | 2016 | 534 | 0.230 |
Why?
|
| Procollagen-Proline Dioxygenase | 4 | 1997 | 81 | 0.230 |
Why?
|
| Raynaud Disease | 1 | 2024 | 79 | 0.230 |
Why?
|
| Prothrombin | 1 | 2024 | 191 | 0.230 |
Why?
|
| Immunity | 3 | 2018 | 998 | 0.220 |
Why?
|
| Heart Diseases | 3 | 2016 | 2809 | 0.220 |
Why?
|
| Aged, 80 and over | 39 | 2024 | 58980 | 0.220 |
Why?
|
| Anorexia Nervosa | 3 | 2019 | 1361 | 0.220 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2024 | 99 | 0.220 |
Why?
|
| Sleep | 3 | 2014 | 4750 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1135 | 0.220 |
Why?
|
| Public Health | 1 | 2017 | 2653 | 0.220 |
Why?
|
| Anthropometry | 4 | 2017 | 1348 | 0.220 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1345 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 19 | 2011 | 6065 | 0.220 |
Why?
|
| Colorectal Neoplasms | 6 | 2019 | 6853 | 0.220 |
Why?
|
| Duty to Recontact | 1 | 2022 | 19 | 0.210 |
Why?
|
| DNA Mutational Analysis | 11 | 2017 | 4108 | 0.210 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2023 | 27 | 0.210 |
Why?
|
| Tissue Banks | 1 | 2004 | 184 | 0.210 |
Why?
|
| Blood Pressure | 6 | 2018 | 8525 | 0.210 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 858 | 0.210 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2014 | 169 | 0.210 |
Why?
|
| Introns | 11 | 2021 | 978 | 0.210 |
Why?
|
| Cholesterol, LDL | 5 | 2022 | 2420 | 0.210 |
Why?
|
| Dyslipidemias | 3 | 2021 | 895 | 0.210 |
Why?
|
| Calcitonin | 5 | 1995 | 330 | 0.200 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 11902 | 0.200 |
Why?
|
| Tryptamines | 2 | 2016 | 93 | 0.200 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2002 | 72 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2024 | 358 | 0.200 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2014 | 599 | 0.200 |
Why?
|
| Coronary Disease | 5 | 2018 | 5991 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 1997 | 194 | 0.200 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 6 | 2001 | 134 | 0.200 |
Why?
|
| Otitis Media | 1 | 2024 | 285 | 0.200 |
Why?
|
| Puberty, Delayed | 3 | 2024 | 121 | 0.200 |
Why?
|
| Mannose-Binding Lectin | 2 | 2022 | 146 | 0.200 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2021 | 11 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2019 | 3426 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 105 | 0.190 |
Why?
|
| Brain Diseases | 3 | 2018 | 1540 | 0.190 |
Why?
|
| Low Tension Glaucoma | 1 | 2021 | 22 | 0.190 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2003 | 413 | 0.190 |
Why?
|
| Leukemia, Myeloid | 2 | 1996 | 696 | 0.190 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 274 | 0.190 |
Why?
|
| Ichthyosis, Lamellar | 2 | 1999 | 11 | 0.190 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2022 | 693 | 0.190 |
Why?
|
| Gene Expression | 10 | 2016 | 7587 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2017 | 342 | 0.190 |
Why?
|
| Transcription, Genetic | 9 | 2018 | 7593 | 0.190 |
Why?
|
| Physical Chromosome Mapping | 5 | 2020 | 182 | 0.190 |
Why?
|
| Myeloproliferative Disorders | 2 | 2020 | 612 | 0.190 |
Why?
|
| Membrane Glycoproteins | 6 | 2016 | 3709 | 0.190 |
Why?
|
| Varicose Veins | 1 | 2023 | 155 | 0.190 |
Why?
|
| Endothelial Growth Factors | 3 | 1998 | 673 | 0.190 |
Why?
|
| Polypharmacy | 1 | 2024 | 307 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2021 | 79 | 0.190 |
Why?
|
| Gene Expression Profiling | 10 | 2019 | 9406 | 0.190 |
Why?
|
| Genomic Structural Variation | 1 | 2021 | 63 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 6 | 2017 | 1602 | 0.180 |
Why?
|
| Crohn Disease | 5 | 2022 | 2275 | 0.180 |
Why?
|
| Mosaicism | 1 | 2024 | 466 | 0.180 |
Why?
|
| Hyperlipidemia, Familial Combined | 2 | 2016 | 14 | 0.180 |
Why?
|
| Clozapine | 1 | 2024 | 506 | 0.180 |
Why?
|
| Telomere | 3 | 2013 | 934 | 0.180 |
Why?
|
| Cytokines | 7 | 2021 | 7344 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2023 | 311 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2020 | 3390 | 0.180 |
Why?
|
| Mucin-5B | 1 | 2021 | 147 | 0.180 |
Why?
|
| Receptor, Endothelin A | 2 | 2011 | 56 | 0.180 |
Why?
|
| Cholesterol | 5 | 2021 | 2924 | 0.180 |
Why?
|
| Alzheimer Disease | 6 | 2024 | 8561 | 0.180 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2629 | 0.180 |
Why?
|
| Clone Cells | 1 | 2024 | 1663 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2024 | 551 | 0.180 |
Why?
|
| Proteoglycans | 3 | 2014 | 801 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2001 | 2418 | 0.180 |
Why?
|
| Malocclusion | 1 | 2021 | 131 | 0.180 |
Why?
|
| Depressive Disorder, Major | 6 | 2021 | 4744 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2013 | 385 | 0.180 |
Why?
|
| Exfoliation Syndrome | 1 | 2021 | 113 | 0.180 |
Why?
|
| Expressed Sequence Tags | 3 | 2000 | 250 | 0.180 |
Why?
|
| Peptide Hormones | 1 | 2021 | 132 | 0.180 |
Why?
|
| Chromosome Aberrations | 4 | 2017 | 1767 | 0.170 |
Why?
|
| Epilepsies, Partial | 2 | 2024 | 430 | 0.170 |
Why?
|
| Aspartylglucosylaminase | 5 | 2001 | 5 | 0.170 |
Why?
|
| Stroke | 8 | 2024 | 9952 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2003 | 2275 | 0.170 |
Why?
|
| Ichthyosis | 1 | 2000 | 59 | 0.170 |
Why?
|
| Transglutaminases | 2 | 1999 | 197 | 0.170 |
Why?
|
| Australia | 6 | 2012 | 1290 | 0.170 |
Why?
|
| Cation Transport Proteins | 2 | 2013 | 325 | 0.170 |
Why?
|
| Acyltransferases | 1 | 2021 | 305 | 0.170 |
Why?
|
| Ocular Hypertension | 1 | 2021 | 206 | 0.170 |
Why?
|
| Parturition | 3 | 2018 | 446 | 0.170 |
Why?
|
| Twins, Dizygotic | 3 | 2009 | 236 | 0.170 |
Why?
|
| Transketolase | 1 | 2019 | 9 | 0.170 |
Why?
|
| Pericardium | 1 | 2024 | 675 | 0.170 |
Why?
|
| GTP-Binding Proteins | 2 | 2021 | 951 | 0.170 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 220 | 0.170 |
Why?
|
| Haploinsufficiency | 2 | 2019 | 329 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2024 | 704 | 0.160 |
Why?
|
| Adipose Tissue | 5 | 2024 | 3300 | 0.160 |
Why?
|
| Sex Factors | 12 | 2024 | 10546 | 0.160 |
Why?
|
| Cosmids | 7 | 1998 | 105 | 0.160 |
Why?
|
| Lissencephaly | 1 | 2019 | 36 | 0.160 |
Why?
|
| Cloning, Molecular | 10 | 1998 | 4169 | 0.160 |
Why?
|
| Inheritance Patterns | 5 | 2019 | 340 | 0.160 |
Why?
|
| Animals | 47 | 2024 | 167960 | 0.160 |
Why?
|
| Principal Component Analysis | 4 | 2016 | 939 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2017 | 346 | 0.160 |
Why?
|
| Body Fluid Compartments | 1 | 2019 | 50 | 0.160 |
Why?
|
| RNA-Binding Proteins | 5 | 2022 | 1894 | 0.160 |
Why?
|
| Atherosclerosis | 4 | 2022 | 3518 | 0.160 |
Why?
|
| Shaw Potassium Channels | 2 | 2017 | 20 | 0.160 |
Why?
|
| Biostatistics | 1 | 2020 | 164 | 0.160 |
Why?
|
| Family Health | 6 | 2019 | 1257 | 0.160 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 1437 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2021 | 2896 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2017 | 315 | 0.150 |
Why?
|
| Smoking | 5 | 2015 | 9073 | 0.150 |
Why?
|
| Kidney Neoplasms | 4 | 2005 | 4312 | 0.150 |
Why?
|
| Centromere | 2 | 2015 | 213 | 0.150 |
Why?
|
| Hypertriglyceridemia | 2 | 2019 | 316 | 0.150 |
Why?
|
| DNA Primers | 9 | 2003 | 2818 | 0.150 |
Why?
|
| Biological Psychiatry | 1 | 2017 | 26 | 0.150 |
Why?
|
| Heart Atria | 1 | 2024 | 1346 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 7 | 2021 | 4408 | 0.150 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2017 | 60 | 0.150 |
Why?
|
| Fibrinolysis | 1 | 1999 | 332 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 1288 | 0.150 |
Why?
|
| Verbal Learning | 2 | 2022 | 462 | 0.150 |
Why?
|
| Twins, Monozygotic | 3 | 2012 | 469 | 0.150 |
Why?
|
| Alcoholism | 3 | 2020 | 1961 | 0.150 |
Why?
|
| Amino Acid Sequence | 16 | 2020 | 13451 | 0.140 |
Why?
|
| Severity of Illness Index | 9 | 2024 | 15840 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2022 | 646 | 0.140 |
Why?
|
| Recombination, Genetic | 3 | 2020 | 1526 | 0.140 |
Why?
|
| Genetic Drift | 2 | 2014 | 41 | 0.140 |
Why?
|
| Frameshift Mutation | 2 | 1996 | 388 | 0.140 |
Why?
|
| Infant, Newborn | 15 | 2024 | 26179 | 0.140 |
Why?
|
| Lysosomal Storage Diseases | 4 | 2001 | 79 | 0.140 |
Why?
|
| Child | 32 | 2024 | 79799 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 893 | 0.140 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1881 | 0.140 |
Why?
|
| Models, Molecular | 5 | 2020 | 5434 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2023 | 650 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1996 | 32 | 0.140 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2016 | 8 | 0.140 |
Why?
|
| Maternal-Child Health Centers | 1 | 1996 | 42 | 0.140 |
Why?
|
| Jews | 1 | 2018 | 364 | 0.130 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2016 | 89 | 0.130 |
Why?
|
| Age of Onset | 8 | 2021 | 3302 | 0.130 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.130 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2016 | 88 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 1 | 2017 | 263 | 0.130 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2014 | 116 | 0.130 |
Why?
|
| Plasma | 1 | 2019 | 584 | 0.130 |
Why?
|
| Biology | 1 | 2018 | 290 | 0.130 |
Why?
|
| Speech | 1 | 2021 | 550 | 0.130 |
Why?
|
| Sciatica | 1 | 2016 | 97 | 0.130 |
Why?
|
| Antigens, CD34 | 1 | 1998 | 653 | 0.130 |
Why?
|
| ABO Blood-Group System | 2 | 2021 | 369 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 978 | 0.130 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.130 |
Why?
|
| Microfilament Proteins | 3 | 2016 | 1135 | 0.130 |
Why?
|
| Rare Diseases | 2 | 2018 | 619 | 0.130 |
Why?
|
| Connexin 43 | 1 | 2016 | 200 | 0.130 |
Why?
|
| Anemia, Macrocytic | 1 | 1995 | 54 | 0.130 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2015 | 15 | 0.130 |
Why?
|
| Denmark | 4 | 2019 | 760 | 0.130 |
Why?
|
| Hyperlipoproteinemia Type II | 3 | 2017 | 396 | 0.120 |
Why?
|
| Epilepsy, Absence | 1 | 2015 | 49 | 0.120 |
Why?
|
| Fetus | 4 | 2016 | 1859 | 0.120 |
Why?
|
| Receptors, Neuropeptide | 1 | 2015 | 105 | 0.120 |
Why?
|
| Translocation, Genetic | 3 | 2017 | 1388 | 0.120 |
Why?
|
| HMGN1 Protein | 1 | 2015 | 27 | 0.120 |
Why?
|
| Acetylglucosamine | 1 | 1996 | 189 | 0.120 |
Why?
|
| Reproducibility of Results | 16 | 2019 | 20080 | 0.120 |
Why?
|
| Epilepsy, Reflex | 1 | 2015 | 25 | 0.120 |
Why?
|
| Gestational Age | 2 | 2017 | 3564 | 0.120 |
Why?
|
| Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
| Blood Coagulation | 2 | 2013 | 1157 | 0.120 |
Why?
|
| Spasms, Infantile | 2 | 2016 | 296 | 0.120 |
Why?
|
| Transcortin | 1 | 2014 | 13 | 0.120 |
Why?
|
| Longitudinal Studies | 9 | 2024 | 14494 | 0.120 |
Why?
|
| Personality Inventory | 3 | 2012 | 1018 | 0.120 |
Why?
|
| Sepharose | 1 | 1994 | 105 | 0.120 |
Why?
|
| Long QT Syndrome | 2 | 2009 | 466 | 0.120 |
Why?
|
| Obesity | 7 | 2021 | 12919 | 0.120 |
Why?
|
| Platelet Activation | 1 | 1998 | 660 | 0.120 |
Why?
|
| Chromosomes, Artificial, Yeast | 5 | 1999 | 113 | 0.120 |
Why?
|
| Receptors, Nicotinic | 2 | 2014 | 494 | 0.120 |
Why?
|
| Mice | 25 | 2024 | 81209 | 0.120 |
Why?
|
| Seafood | 1 | 2017 | 390 | 0.120 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 169 | 0.120 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2014 | 23 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3617 | 0.120 |
Why?
|
| Granulocytes | 1 | 1996 | 551 | 0.120 |
Why?
|
| Basement Membrane | 3 | 1984 | 348 | 0.120 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3759 | 0.120 |
Why?
|
| Receptors, CXCR3 | 1 | 2015 | 238 | 0.120 |
Why?
|
| Monoamine Oxidase | 1 | 2014 | 178 | 0.120 |
Why?
|
| Ovarian Follicle | 2 | 1987 | 244 | 0.120 |
Why?
|
| Transcription Factors | 9 | 2019 | 12102 | 0.120 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 245 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 8 | 2021 | 5782 | 0.120 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 1504 | 0.120 |
Why?
|
| Body Weight | 2 | 2017 | 4611 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 436 | 0.110 |
Why?
|
| Lipoproteins, LDL | 4 | 2020 | 641 | 0.110 |
Why?
|
| Hypercalcemia | 1 | 2017 | 421 | 0.110 |
Why?
|
| Prevalence | 7 | 2020 | 15686 | 0.110 |
Why?
|
| Hypercholesterolemia | 2 | 2019 | 1155 | 0.110 |
Why?
|
| Glycoproteins | 5 | 2021 | 2208 | 0.110 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 5 | 1999 | 144 | 0.110 |
Why?
|
| Gene Rearrangement | 4 | 2006 | 1122 | 0.110 |
Why?
|
| Zinc Fingers | 2 | 2012 | 568 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 1242 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2023 | 4263 | 0.110 |
Why?
|
| Optic Atrophy | 1 | 2014 | 78 | 0.110 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 1999 | 330 | 0.110 |
Why?
|
| Chromosome Deletion | 3 | 2013 | 1387 | 0.110 |
Why?
|
| Fiber Optic Technology | 1 | 1995 | 289 | 0.110 |
Why?
|
| Software | 5 | 2019 | 4419 | 0.110 |
Why?
|
| Genes, Dominant | 3 | 2014 | 863 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2020 | 4496 | 0.110 |
Why?
|
| Hemiplegia | 2 | 2004 | 136 | 0.110 |
Why?
|
| Evolution, Molecular | 3 | 2011 | 1885 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 491 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2253 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 263 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 316 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2873 | 0.110 |
Why?
|
| Anxiety Disorders | 2 | 2015 | 2714 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 2023 | 4938 | 0.110 |
Why?
|
| Leigh Disease | 1 | 2014 | 89 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 613 | 0.110 |
Why?
|
| Fasting | 2 | 2017 | 1603 | 0.110 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 3 | 1997 | 59 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2003 | 2802 | 0.110 |
Why?
|
| Insulin | 4 | 2017 | 6596 | 0.110 |
Why?
|
| Intelligence | 1 | 2018 | 919 | 0.110 |
Why?
|
| Seizures | 2 | 2024 | 2917 | 0.110 |
Why?
|
| Odds Ratio | 9 | 2017 | 9716 | 0.110 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1171 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2016 | 1152 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 475 | 0.110 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2013 | 85 | 0.110 |
Why?
|
| Somatoform Disorders | 1 | 2016 | 423 | 0.110 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2013 | 72 | 0.110 |
Why?
|
| Hemochromatosis | 2 | 2008 | 174 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 7 | 1991 | 761 | 0.110 |
Why?
|
| Learning | 1 | 2022 | 1739 | 0.110 |
Why?
|
| Chronic Disease | 7 | 2024 | 9288 | 0.100 |
Why?
|
| Hashimoto Disease | 1 | 2014 | 105 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2131 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2021 | 822 | 0.100 |
Why?
|
| Data Mining | 2 | 2023 | 553 | 0.100 |
Why?
|
| Genes, ras | 2 | 1993 | 654 | 0.100 |
Why?
|
| Depression | 4 | 2023 | 8045 | 0.100 |
Why?
|
| Population Groups | 2 | 2010 | 211 | 0.100 |
Why?
|
| Age Factors | 11 | 2024 | 18413 | 0.100 |
Why?
|
| Methylation | 6 | 2012 | 1081 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 911 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1652 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1888 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1425 | 0.100 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3959 | 0.100 |
Why?
|
| Body Composition | 2 | 2019 | 2419 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 122 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2013 | 241 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2014 | 294 | 0.100 |
Why?
|
| Graves Disease | 1 | 2014 | 239 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 924 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 166 | 0.100 |
Why?
|
| Gene Dosage | 3 | 2023 | 1218 | 0.100 |
Why?
|
| RNA Splicing | 1 | 1997 | 915 | 0.100 |
Why?
|
| Suicide | 2 | 2022 | 1599 | 0.100 |
Why?
|
| Prognosis | 13 | 2020 | 29661 | 0.100 |
Why?
|
| Ataxia | 1 | 2014 | 305 | 0.100 |
Why?
|
| Karyotyping | 5 | 2017 | 1172 | 0.100 |
Why?
|
| alpha Catenin | 1 | 2011 | 37 | 0.100 |
Why?
|
| Gene Regulatory Networks | 4 | 2019 | 1741 | 0.100 |
Why?
|
| Oligodendroglia | 1 | 2015 | 536 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2005 | 3218 | 0.100 |
Why?
|
| Aquaporins | 1 | 2012 | 174 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 679 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2015 | 926 | 0.100 |
Why?
|
| Candidiasis | 2 | 2005 | 363 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 833 | 0.100 |
Why?
|
| Growth Disorders | 3 | 2008 | 653 | 0.100 |
Why?
|
| Ubiquitin | 1 | 2016 | 838 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4571 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 387 | 0.090 |
Why?
|
| Desmosomes | 1 | 2011 | 72 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 3 | 2008 | 457 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 286 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1380 | 0.090 |
Why?
|
| Cerebellum | 3 | 2016 | 1495 | 0.090 |
Why?
|
| Synapses | 3 | 2017 | 1757 | 0.090 |
Why?
|
| Liver | 5 | 2021 | 7510 | 0.090 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 4013 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1356 | 0.090 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 912 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 3765 | 0.090 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 291 | 0.090 |
Why?
|
| Gene Pool | 1 | 2010 | 35 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3817 | 0.090 |
Why?
|
| DNA-Directed DNA Polymerase | 3 | 2012 | 491 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2017 | 2860 | 0.090 |
Why?
|
| Lipoproteins | 3 | 2011 | 882 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 211 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1057 | 0.090 |
Why?
|
| Frontal Lobe | 2 | 2016 | 1420 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 365 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1846 | 0.090 |
Why?
|
| Hostility | 1 | 2011 | 183 | 0.090 |
Why?
|
| Infant | 16 | 2021 | 36053 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 1617 | 0.090 |
Why?
|
| Hypertension | 3 | 2021 | 8595 | 0.090 |
Why?
|
| Siblings | 3 | 2011 | 824 | 0.090 |
Why?
|
| Family | 7 | 2019 | 3189 | 0.090 |
Why?
|
| Fatty Acids | 2 | 2017 | 1804 | 0.090 |
Why?
|
| Brain Ischemia | 2 | 2015 | 3127 | 0.090 |
Why?
|
| Serpins | 2 | 2003 | 247 | 0.090 |
Why?
|
| Blood Platelets | 2 | 1998 | 2519 | 0.090 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 1077 | 0.090 |
Why?
|
| Metabolomics | 3 | 2022 | 1628 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2021 | 3763 | 0.090 |
Why?
|
| Temperament | 1 | 2012 | 295 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 716 | 0.080 |
Why?
|
| Environment | 2 | 2008 | 1118 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2448 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3701 | 0.080 |
Why?
|
| Apolipoprotein B-100 | 3 | 2020 | 155 | 0.080 |
Why?
|
| Biological Clocks | 1 | 2012 | 316 | 0.080 |
Why?
|
| Sweden | 3 | 2006 | 1381 | 0.080 |
Why?
|
| Germany | 3 | 2019 | 873 | 0.080 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 3454 | 0.080 |
Why?
|
| Analgesics | 1 | 2016 | 1065 | 0.080 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2012 | 250 | 0.080 |
Why?
|
| Brain | 10 | 2022 | 26951 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2012 | 534 | 0.080 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2011 | 162 | 0.080 |
Why?
|
| Mental Processes | 1 | 2010 | 245 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 2 | 2007 | 113 | 0.080 |
Why?
|
| Thyroxine | 1 | 2013 | 667 | 0.080 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 134 | 0.080 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 11890 | 0.080 |
Why?
|
| Hypothyroidism | 2 | 2013 | 665 | 0.080 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 305 | 0.080 |
Why?
|
| Breast Neoplasms | 6 | 2020 | 21029 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2916 | 0.080 |
Why?
|
| Molecular Biology | 1 | 1993 | 580 | 0.080 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 39262 | 0.080 |
Why?
|
| Scotoma | 1 | 2010 | 130 | 0.080 |
Why?
|
| Hemoglobin, Sickle | 1 | 2009 | 113 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 1084 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2009 | 141 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2013 | 2668 | 0.080 |
Why?
|
| Arm | 1 | 2012 | 583 | 0.080 |
Why?
|
| Inflammation | 2 | 2023 | 10755 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1575 | 0.080 |
Why?
|
| Osteoarthritis | 3 | 1993 | 1055 | 0.080 |
Why?
|
| Versicans | 2 | 2019 | 40 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2000 | 278 | 0.080 |
Why?
|
| Disease Progression | 2 | 2024 | 13505 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2141 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 380 | 0.080 |
Why?
|
| Adolescent Development | 1 | 2012 | 282 | 0.080 |
Why?
|
| Neoplasms | 5 | 2020 | 22075 | 0.080 |
Why?
|
| Risk Assessment | 9 | 2024 | 24102 | 0.080 |
Why?
|
| Risk | 6 | 2021 | 9632 | 0.080 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 81 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2012 | 457 | 0.080 |
Why?
|
| Violence | 1 | 2014 | 927 | 0.080 |
Why?
|
| Neuropsychological Tests | 6 | 2024 | 7022 | 0.080 |
Why?
|
| Selection, Genetic | 2 | 2012 | 870 | 0.080 |
Why?
|
| Primates | 1 | 2010 | 523 | 0.080 |
Why?
|
| International Cooperation | 5 | 2018 | 1433 | 0.080 |
Why?
|
| Comorbidity | 7 | 2021 | 10553 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 652 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
| Colitis, Ulcerative | 2 | 2019 | 1919 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2008 | 224 | 0.080 |
Why?
|
| Molecular Epidemiology | 3 | 2018 | 469 | 0.070 |
Why?
|
| Prospective Studies | 12 | 2024 | 54306 | 0.070 |
Why?
|
| Histocompatibility | 1 | 2009 | 316 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 788 | 0.070 |
Why?
|
| Astrocytes | 1 | 2015 | 1337 | 0.070 |
Why?
|
| Diabetes Mellitus | 3 | 2021 | 5890 | 0.070 |
Why?
|
| Telomerase | 1 | 2013 | 747 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 1999 | 228 | 0.070 |
Why?
|
| Pregnancy | 12 | 2024 | 29746 | 0.070 |
Why?
|
| Cause of Death | 3 | 2015 | 3725 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2024 | 3787 | 0.070 |
Why?
|
| Leptin | 1 | 2016 | 1590 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2008 | 1355 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1181 | 0.070 |
Why?
|
| Microbial Collagenase | 2 | 1987 | 113 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 1115 | 0.070 |
Why?
|
| Transferrin | 1 | 2008 | 284 | 0.070 |
Why?
|
| Procollagen | 6 | 1993 | 188 | 0.070 |
Why?
|
| Pseudogenes | 2 | 1997 | 103 | 0.070 |
Why?
|
| Eye Proteins | 2 | 2021 | 633 | 0.070 |
Why?
|
| Ovulation | 2 | 1987 | 181 | 0.070 |
Why?
|
| Endothelin-1 | 1 | 2009 | 302 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2012 | 6379 | 0.070 |
Why?
|
| Lipase | 2 | 2020 | 324 | 0.070 |
Why?
|
| Eye Abnormalities | 2 | 2019 | 241 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2014 | 1197 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2004 | 1055 | 0.070 |
Why?
|
| Hospitalization | 2 | 2024 | 10789 | 0.070 |
Why?
|
| Myosins | 1 | 2009 | 405 | 0.070 |
Why?
|
| Medical History Taking | 2 | 2022 | 773 | 0.070 |
Why?
|
| Models, Neurological | 2 | 2014 | 1758 | 0.070 |
Why?
|
| DNA, Complementary | 7 | 1999 | 1991 | 0.070 |
Why?
|
| Immunohistochemistry | 7 | 2015 | 11070 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4673 | 0.070 |
Why?
|
| Time Factors | 10 | 2020 | 40139 | 0.070 |
Why?
|
| Plasminogen Activators | 1 | 1987 | 199 | 0.070 |
Why?
|
| Antigens, Neoplasm | 4 | 2003 | 1998 | 0.070 |
Why?
|
| Child, Preschool | 13 | 2021 | 42056 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2332 | 0.070 |
Why?
|
| Molecular Sequence Annotation | 2 | 2022 | 524 | 0.070 |
Why?
|
| Blood Proteins | 2 | 2024 | 1173 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2015 | 2773 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2015 | 1518 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 1110 | 0.070 |
Why?
|
| Databases, Factual | 6 | 2019 | 8022 | 0.070 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 418 | 0.070 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2007 | 151 | 0.070 |
Why?
|
| Twins | 4 | 2012 | 339 | 0.070 |
Why?
|
| Genome | 3 | 2009 | 1739 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 2012 | 2942 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2001 | 1613 | 0.070 |
Why?
|
| Health Surveys | 2 | 2013 | 4063 | 0.070 |
Why?
|
| Executive Function | 1 | 2015 | 1374 | 0.070 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 1997 | 120 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2014 | 1803 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2012 | 1074 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 1245 | 0.070 |
Why?
|
| Head | 1 | 2012 | 922 | 0.070 |
Why?
|
| Demyelinating Diseases | 1 | 2008 | 351 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2013 | 1168 | 0.070 |
Why?
|
| Taste | 1 | 2007 | 188 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1305 | 0.070 |
Why?
|
| Death, Sudden | 2 | 2015 | 302 | 0.070 |
Why?
|
| Mothers | 2 | 2023 | 2186 | 0.070 |
Why?
|
| Contracture | 2 | 1998 | 235 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2011 | 14661 | 0.060 |
Why?
|
| Protein Conformation | 4 | 2020 | 3970 | 0.060 |
Why?
|
| Amino Acid Substitution | 3 | 2019 | 1737 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 877 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 1303 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2005 | 0.060 |
Why?
|
| Syndrome | 8 | 2019 | 3280 | 0.060 |
Why?
|
| Heparitin Sulfate | 2 | 1983 | 224 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2006 | 275 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1557 | 0.060 |
Why?
|
| COS Cells | 2 | 1997 | 1129 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 1810 | 0.060 |
Why?
|
| X Chromosome | 3 | 1998 | 815 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 3 | 2017 | 1067 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 5209 | 0.060 |
Why?
|
| Sequence Homology | 2 | 2020 | 195 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1995 | 1401 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2014 | 2119 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 2421 | 0.060 |
Why?
|
| Mitochondria | 2 | 2014 | 3601 | 0.060 |
Why?
|
| Polyendocrinopathies, Autoimmune | 2 | 1997 | 55 | 0.060 |
Why?
|
| Aorta | 2 | 2022 | 2039 | 0.060 |
Why?
|
| Japan | 3 | 2014 | 1369 | 0.060 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2004 | 18 | 0.060 |
Why?
|
| Metabolome | 1 | 2012 | 982 | 0.060 |
Why?
|
| Laminin | 3 | 1999 | 405 | 0.060 |
Why?
|
| Smell | 1 | 2007 | 259 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2024 | 69 | 0.060 |
Why?
|
| Codon | 2 | 1997 | 602 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4924 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2008 | 368 | 0.060 |
Why?
|
| Conserved Sequence | 3 | 2017 | 1167 | 0.060 |
Why?
|
| Lipoproteins, HDL | 3 | 2017 | 667 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 2 | 2021 | 928 | 0.060 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2004 | 44 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2003 | 8512 | 0.060 |
Why?
|
| Lymphokines | 2 | 1998 | 927 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2017 | 23374 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3094 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4167 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 3 | 2021 | 1344 | 0.060 |
Why?
|
| Cells, Cultured | 10 | 2019 | 18955 | 0.060 |
Why?
|
| Netherlands | 2 | 2011 | 2213 | 0.060 |
Why?
|
| Quality Control | 4 | 2010 | 828 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 330 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 829 | 0.060 |
Why?
|
| Sample Size | 3 | 2016 | 840 | 0.060 |
Why?
|
| Menopause | 1 | 2012 | 1640 | 0.060 |
Why?
|
| Food Preferences | 1 | 2007 | 399 | 0.060 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2003 | 33 | 0.060 |
Why?
|
| Scotland | 2 | 2015 | 143 | 0.060 |
Why?
|
| Acetazolamide | 1 | 2004 | 96 | 0.060 |
Why?
|
| Calcium | 1 | 2017 | 5725 | 0.060 |
Why?
|
| Russia | 1 | 2024 | 381 | 0.060 |
Why?
|
| Fibronectins | 3 | 1990 | 722 | 0.060 |
Why?
|
| Vestibular Nerve | 1 | 2003 | 101 | 0.060 |
Why?
|
| Twin Studies as Topic | 1 | 2003 | 104 | 0.060 |
Why?
|
| GPI-Linked Proteins | 2 | 2017 | 468 | 0.060 |
Why?
|
| Germ-Line Mutation | 2 | 2024 | 1842 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2020 | 2611 | 0.060 |
Why?
|
| Demography | 1 | 2008 | 1650 | 0.050 |
Why?
|
| Eustachian Tube | 1 | 2024 | 96 | 0.050 |
Why?
|
| Songbirds | 1 | 2003 | 23 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 2022 | 1608 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 1720 | 0.050 |
Why?
|
| Cell Line | 8 | 2022 | 15620 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2005 | 551 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4371 | 0.050 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2024 | 149 | 0.050 |
Why?
|
| Population Surveillance | 3 | 2018 | 2608 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1983 | 141 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2024 | 162 | 0.050 |
Why?
|
| Apolipoprotein C-III | 2 | 2022 | 209 | 0.050 |
Why?
|
| Sequence Alignment | 4 | 2014 | 2176 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2024 | 233 | 0.050 |
Why?
|
| Restriction Mapping | 4 | 1999 | 852 | 0.050 |
Why?
|
| Contig Mapping | 2 | 2001 | 54 | 0.050 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 186 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2014 | 3040 | 0.050 |
Why?
|
| Puberty, Precocious | 1 | 2024 | 163 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2022 | 8556 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2024 | 302 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2024 | 241 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2015 | 3905 | 0.050 |
Why?
|
| INDEL Mutation | 2 | 2015 | 266 | 0.050 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 39 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2024 | 788 | 0.050 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2002 | 94 | 0.050 |
Why?
|
| F-Box Proteins | 1 | 2024 | 202 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2038 | 0.050 |
Why?
|
| Fragile X Syndrome | 2 | 2001 | 116 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 580 | 0.050 |
Why?
|
| Carbonic Anhydrases | 1 | 2003 | 109 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2003 | 211 | 0.050 |
Why?
|
| Thrombosis | 2 | 2024 | 3051 | 0.050 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2002 | 81 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2210 | 0.050 |
Why?
|
| Retinal Dystrophies | 1 | 2023 | 64 | 0.050 |
Why?
|
| Phylogeny | 3 | 2020 | 2775 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 2365 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1998 | 777 | 0.050 |
Why?
|
| Arthritis, Reactive | 1 | 2002 | 20 | 0.050 |
Why?
|
| Endoderm | 1 | 1983 | 160 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 7 | 2002 | 6130 | 0.050 |
Why?
|
| Spondylarthropathies | 1 | 2002 | 14 | 0.050 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Reference Values | 5 | 2016 | 4925 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 2924 | 0.050 |
Why?
|
| Metaphase | 3 | 1999 | 144 | 0.050 |
Why?
|
| Cerebellar Ataxia | 1 | 2003 | 149 | 0.050 |
Why?
|
| Central Nervous System | 2 | 2022 | 1334 | 0.050 |
Why?
|
| Heat-Shock Proteins | 2 | 2014 | 795 | 0.050 |
Why?
|
| Ear, Middle | 1 | 2024 | 338 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 8985 | 0.050 |
Why?
|
| Electronic Health Records | 3 | 2024 | 4775 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2021 | 2532 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 163 | 0.050 |
Why?
|
| Nerve Net | 1 | 2014 | 2261 | 0.050 |
Why?
|
| Cerebellar Diseases | 1 | 2003 | 219 | 0.050 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2021 | 4 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3726 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15286 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Genes, Lethal | 2 | 1998 | 225 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2698 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10181 | 0.050 |
Why?
|
| Logistic Models | 6 | 2017 | 13312 | 0.050 |
Why?
|
| Carnitine | 1 | 2022 | 251 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor C | 2 | 1998 | 127 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 351 | 0.050 |
Why?
|
| Genome, Mitochondrial | 1 | 2021 | 66 | 0.050 |
Why?
|
| Placenta | 2 | 2024 | 1702 | 0.050 |
Why?
|
| Serpin E2 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Algorithms | 5 | 2023 | 13982 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 749 | 0.050 |
Why?
|
| Endothelium | 1 | 1983 | 764 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2000 | 21 | 0.050 |
Why?
|
| Overweight | 1 | 2012 | 2421 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2017 | 6359 | 0.050 |
Why?
|
| Bilirubin | 1 | 2022 | 438 | 0.040 |
Why?
|
| Muscle Hypotonia | 2 | 2019 | 160 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 1983 | 605 | 0.040 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 132 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2022 | 320 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3549 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1998 | 285 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3332 | 0.040 |
Why?
|
| CpG Islands | 2 | 2017 | 1221 | 0.040 |
Why?
|
| Thyroglobulin | 1 | 2020 | 111 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2021 | 100 | 0.040 |
Why?
|
| Goiter | 1 | 2020 | 87 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2021 | 195 | 0.040 |
Why?
|
| Trinucleotide Repeats | 2 | 1998 | 257 | 0.040 |
Why?
|
| Incidence | 3 | 2024 | 21391 | 0.040 |
Why?
|
| Ichthyosiform Erythroderma, Congenital | 1 | 1999 | 7 | 0.040 |
Why?
|
| RNA | 3 | 2022 | 2723 | 0.040 |
Why?
|
| Neurologic Examination | 3 | 2010 | 916 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2003 | 3612 | 0.040 |
Why?
|
| Stroke Volume | 2 | 2024 | 5523 | 0.040 |
Why?
|
| Ganglioglioma | 1 | 2019 | 36 | 0.040 |
Why?
|
| European Union | 2 | 2015 | 157 | 0.040 |
Why?
|
| Anticonvulsants | 2 | 2013 | 1879 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2558 | 0.040 |
Why?
|
| Anxiety | 1 | 2014 | 4538 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2021 | 177 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 2753 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 710 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 1998 | 748 | 0.040 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 2 | 2009 | 72 | 0.040 |
Why?
|
| Malaria | 1 | 2009 | 1226 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8010 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3539 | 0.040 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 1999 | 31 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2003 | 1130 | 0.040 |
Why?
|
| Primary Dysautonomias | 1 | 2019 | 28 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1996 | 685 | 0.040 |
Why?
|
| Marfan Syndrome | 2 | 1992 | 236 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4446 | 0.040 |
Why?
|
| Hypoventilation | 1 | 2019 | 44 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11848 | 0.040 |
Why?
|
| Meningocele | 1 | 1999 | 46 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2024 | 607 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 210 | 0.040 |
Why?
|
| Life Style | 2 | 2022 | 3898 | 0.040 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 1998 | 41 | 0.040 |
Why?
|
| Polydactyly | 1 | 1999 | 56 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 1710 | 0.040 |
Why?
|
| Pain | 1 | 2013 | 5066 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2019 | 128 | 0.040 |
Why?
|
| Hemosiderosis | 1 | 1998 | 66 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2063 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 2009 | 240 | 0.040 |
Why?
|
| Cefotaxime | 1 | 2017 | 35 | 0.040 |
Why?
|
| Motor Neuron Disease | 1 | 1998 | 98 | 0.040 |
Why?
|
| Gene Flow | 1 | 2018 | 78 | 0.040 |
Why?
|
| Dwarfism | 1 | 1999 | 137 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1995 | 1745 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 1096 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 25941 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2017 | 93 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2017 | 37 | 0.040 |
Why?
|
| Encephalocele | 1 | 1999 | 135 | 0.040 |
Why?
|
| DNA Probes | 2 | 1995 | 551 | 0.040 |
Why?
|
| Fetal Growth Retardation | 2 | 1998 | 579 | 0.040 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 1997 | 62 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3841 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 55 | 0.040 |
Why?
|
| Population Density | 1 | 2018 | 192 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1988 | 168 | 0.040 |
Why?
|
| Isomerases | 1 | 1997 | 55 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 666 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 1999 | 447 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 1 | 1997 | 102 | 0.040 |
Why?
|
| Syndecans | 1 | 1997 | 75 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2017 | 87 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2013 | 869 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2002 | 785 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2117 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 104 | 0.040 |
Why?
|
| Mental Recall | 1 | 2023 | 1206 | 0.040 |
Why?
|
| Mass Screening | 1 | 2013 | 5422 | 0.040 |
Why?
|
| Austria | 1 | 2017 | 206 | 0.040 |
Why?
|
| HLA-DR Antigens | 2 | 2011 | 630 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2017 | 246 | 0.040 |
Why?
|
| Coronary Thrombosis | 1 | 2000 | 486 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2016 | 14374 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 3026 | 0.030 |
Why?
|
| Heredity | 1 | 2017 | 148 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 156 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12531 | 0.030 |
Why?
|
| NFI Transcription Factors | 1 | 2016 | 42 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2014 | 1572 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2023 | 759 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2000 | 987 | 0.030 |
Why?
|
| Cataract | 1 | 2023 | 827 | 0.030 |
Why?
|
| Venous Thromboembolism | 2 | 2024 | 1864 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 182 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2019 | 343 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 1999 | 514 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2019 | 597 | 0.030 |
Why?
|
| Bone Marrow | 3 | 1996 | 2914 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 1997 | 174 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 1792 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 1999 | 468 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2005 | 10185 | 0.030 |
Why?
|
| Syndecan-1 | 1 | 1997 | 163 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 1996 | 95 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 183 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5039 | 0.030 |
Why?
|
| Mandible | 1 | 2021 | 750 | 0.030 |
Why?
|
| Receptor, Insulin | 2 | 2014 | 836 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1996 | 91 | 0.030 |
Why?
|
| Hypoparathyroidism | 1 | 1997 | 136 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 335 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2852 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2651 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3610 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1999 | 748 | 0.030 |
Why?
|
| Access to Information | 1 | 2019 | 320 | 0.030 |
Why?
|
| Receptors, TIE | 1 | 1995 | 10 | 0.030 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 5795 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1997 | 201 | 0.030 |
Why?
|
| Hypotonic Solutions | 1 | 1995 | 48 | 0.030 |
Why?
|
| Pteridines | 1 | 2015 | 47 | 0.030 |
Why?
|
| Copper | 3 | 1983 | 368 | 0.030 |
Why?
|
| Criminals | 1 | 2016 | 61 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 977 | 0.030 |
Why?
|
| Acute Disease | 4 | 2005 | 7268 | 0.030 |
Why?
|
| Coenzymes | 1 | 2015 | 102 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 503 | 0.030 |
Why?
|
| Metalloproteins | 1 | 2015 | 101 | 0.030 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1995 | 52 | 0.030 |
Why?
|
| Centrifugation | 1 | 1995 | 122 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 518 | 0.030 |
Why?
|
| Xanthine Dehydrogenase | 1 | 1995 | 17 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2017 | 557 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 599 | 0.030 |
Why?
|
| Dimerization | 1 | 1997 | 891 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2097 | 0.030 |
Why?
|
| Ovary | 2 | 2014 | 958 | 0.030 |
Why?
|
| Research Design | 2 | 2024 | 6180 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 3800 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 936 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 979 | 0.030 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1994 | 16 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 488 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 1994 | 59 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 241 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1987 | 2094 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2019 | 755 | 0.030 |
Why?
|
| Histocytochemistry | 3 | 1984 | 700 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
| Polylysine | 1 | 1994 | 131 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 756 | 0.030 |
Why?
|
| Orosomucoid | 1 | 2014 | 47 | 0.030 |
Why?
|
| Morbidity | 1 | 2020 | 1765 | 0.030 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 3839 | 0.030 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1997 | 282 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2022 | 850 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 313 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 138 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 1994 | 309 | 0.030 |
Why?
|
| Prostate | 1 | 2002 | 1793 | 0.030 |
Why?
|
| Transfection | 2 | 2004 | 5781 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2014 | 149 | 0.030 |
Why?
|
| Memory | 1 | 2024 | 2179 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 700 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2009 | 5659 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Aspartylglucosaminuria | 1 | 1993 | 2 | 0.030 |
Why?
|
| Protein-Lysine 6-Oxidase | 3 | 1983 | 54 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2019 | 64981 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2001 | 1264 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 123 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 1378 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 568 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.030 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2014 | 101 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2864 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 1994 | 211 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1628 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2016 | 428 | 0.030 |
Why?
|
| Arabs | 1 | 1996 | 187 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1249 | 0.030 |
Why?
|
| Education | 1 | 2016 | 534 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1004 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 416 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 1994 | 222 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2019 | 1403 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1997 | 661 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2014 | 178 | 0.030 |
Why?
|
| Finger Joint | 1 | 1993 | 108 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 229 | 0.030 |
Why?
|
| Prions | 1 | 2014 | 179 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2005 | 3047 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 85 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1995 | 546 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 680 | 0.030 |
Why?
|
| Apolipoprotein A-II | 1 | 2012 | 41 | 0.030 |
Why?
|
| Zebrafish | 2 | 2015 | 2997 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2020 | 1262 | 0.030 |
Why?
|
| Liver Diseases | 2 | 1998 | 1302 | 0.030 |
Why?
|
| Linear Models | 2 | 2013 | 5877 | 0.030 |
Why?
|
| MADS Domain Proteins | 1 | 2012 | 19 | 0.030 |
Why?
|
| Thrombocythemia, Essential | 1 | 1994 | 107 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2014 | 226 | 0.030 |
Why?
|
| Sulfites | 1 | 2012 | 83 | 0.030 |
Why?
|
| Consanguinity | 2 | 2012 | 456 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1736 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 2095 | 0.030 |
Why?
|
| Lysine | 1 | 1997 | 1001 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1997 | 1089 | 0.030 |
Why?
|
| Seizures, Febrile | 1 | 2013 | 108 | 0.030 |
Why?
|
| Longevity | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 282 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 759 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2017 | 499 | 0.030 |
Why?
|
| Oxycodone | 1 | 2013 | 138 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1091 | 0.030 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 11345 | 0.030 |
Why?
|
| Polycythemia Vera | 1 | 1994 | 160 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 425 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2012 | 103 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2012 | 159 | 0.030 |
Why?
|
| Electrocardiography | 3 | 2011 | 6415 | 0.030 |
Why?
|
| Benzene | 1 | 1992 | 106 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 374 | 0.030 |
Why?
|
| Sex Ratio | 1 | 2012 | 107 | 0.030 |
Why?
|
| ras Proteins | 1 | 2017 | 1051 | 0.030 |
Why?
|
| Models, Statistical | 3 | 2014 | 5075 | 0.020 |
Why?
|
| Influenza B virus | 1 | 2012 | 52 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2250 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2018 | 1016 | 0.020 |
Why?
|
| Protein Folding | 1 | 1996 | 867 | 0.020 |
Why?
|
| Larva | 1 | 2013 | 509 | 0.020 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 83 | 0.020 |
Why?
|
| Primary Myelofibrosis | 1 | 1994 | 210 | 0.020 |
Why?
|
| Polysomnography | 1 | 2018 | 1825 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1173 | 0.020 |
Why?
|
| Neurofibromatosis 2 | 1 | 1995 | 385 | 0.020 |
Why?
|
| Turkey | 1 | 2012 | 248 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 36286 | 0.020 |
Why?
|
| Reaction Time | 1 | 2018 | 2075 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1982 | 149 | 0.020 |
Why?
|
| Desmoglein 2 | 1 | 2011 | 12 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.020 |
Why?
|
| Receptors, FSH | 1 | 2011 | 29 | 0.020 |
Why?
|
| Connective Tissue Diseases | 3 | 1988 | 286 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1996 | 1021 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 139 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2012 | 197 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1657 | 0.020 |
Why?
|
| Plakophilins | 1 | 2011 | 32 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2013 | 255 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 230 | 0.020 |
Why?
|
| Magnetics | 1 | 1994 | 600 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 247 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2013 | 258 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2011 | 225 | 0.020 |
Why?
|
| Desmoplakins | 1 | 2011 | 62 | 0.020 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1990 | 6 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2671 | 0.020 |
Why?
|
| Ammonia-Lyases | 1 | 1990 | 6 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1991 | 101 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 301 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1109 | 0.020 |
Why?
|
| Fibroblasts | 4 | 2016 | 4089 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2014 | 674 | 0.020 |
Why?
|
| England | 1 | 2012 | 526 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2012 | 311 | 0.020 |
Why?
|
| Amino Acids | 2 | 2012 | 1714 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2021 | 80345 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1964 | 0.020 |
Why?
|
| Porphyrias | 1 | 1990 | 58 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 195 | 0.020 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 735 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2015 | 1047 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1995 | 1085 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 691 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4356 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 2418 | 0.020 |
Why?
|
| Spain | 1 | 2011 | 488 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 877 | 0.020 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2010 | 81 | 0.020 |
Why?
|
| Neurons | 2 | 2022 | 9424 | 0.020 |
Why?
|
| Health Behavior | 1 | 2022 | 2622 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1995 | 1666 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 243 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 699 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 698 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1635 | 0.020 |
Why?
|
| Biosynthetic Pathways | 1 | 2010 | 135 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 1998 | 3484 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2013 | 780 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 345 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1699 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 140 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3442 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2019 | 1940 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2010 | 398 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1792 | 0.020 |
Why?
|
| Kidney | 2 | 2003 | 7064 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9468 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1644 | 0.020 |
Why?
|
| Osteogenesis Imperfecta | 2 | 1980 | 81 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2982 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 841 | 0.020 |
Why?
|
| Gambia | 1 | 2009 | 104 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 273 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 6015 | 0.020 |
Why?
|
| Hypersensitivity | 2 | 2010 | 1155 | 0.020 |
Why?
|
| Plasmids | 1 | 1994 | 2275 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 2 | 2001 | 2882 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 613 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2009 | 130 | 0.020 |
Why?
|
| Keratins | 1 | 2010 | 497 | 0.020 |
Why?
|
| Angiopoietin-1 | 2 | 2001 | 122 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 4434 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2086 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2007 | 2186 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1613 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 732 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 103 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1132 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2009 | 293 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1343 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2012 | 959 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2015 | 3112 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 1304 | 0.020 |
Why?
|
| Hot Temperature | 2 | 2013 | 1435 | 0.020 |
Why?
|
| Basophils | 1 | 2010 | 404 | 0.020 |
Why?
|
| Testis | 2 | 2003 | 794 | 0.020 |
Why?
|
| Gene Conversion | 1 | 2008 | 67 | 0.020 |
Why?
|
| Causality | 1 | 2014 | 1242 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2013 | 570 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 619 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4024 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 448 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1997 | 1705 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2012 | 758 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2003 | 3482 | 0.020 |
Why?
|
| Test Anxiety Scale | 1 | 2007 | 4 | 0.020 |
Why?
|
| Gonadotropins, Equine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 686 | 0.020 |
Why?
|
| Propylthiouracil | 1 | 2007 | 68 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1995 | 1992 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 840 | 0.020 |
Why?
|
| Genomic Library | 2 | 1997 | 189 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2938 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 229 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1126 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2009 | 717 | 0.020 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 1983 | 19 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1816 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 508 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2128 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 827 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3568 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 854 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4542 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 1446 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Health Resources | 1 | 2012 | 935 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 1992 | 1441 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2020 | 2859 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 2825 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 975 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2017 | 2044 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 1827 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 1983 | 92 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 1987 | 260 | 0.020 |
Why?
|
| Autophagy | 1 | 2013 | 1337 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22020 | 0.020 |
Why?
|
| Epithelium | 2 | 2001 | 1605 | 0.020 |
Why?
|
| Mastectomy | 1 | 2013 | 1832 | 0.020 |
Why?
|
| Gene Library | 2 | 1998 | 1060 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1959 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2004 | 3105 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2049 | 0.020 |
Why?
|
| Norway | 1 | 2006 | 496 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 2698 | 0.020 |
Why?
|
| Rats | 3 | 2004 | 23709 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2015 | 3215 | 0.020 |
Why?
|
| Electronystagmography | 1 | 2003 | 25 | 0.010 |
Why?
|
| Blindness | 1 | 1988 | 582 | 0.010 |
Why?
|
| Glioma | 1 | 2019 | 3420 | 0.010 |
Why?
|
| Virus Replication | 1 | 2012 | 2432 | 0.010 |
Why?
|
| Epidermolysis Bullosa | 1 | 1984 | 29 | 0.010 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1983 | 44 | 0.010 |
Why?
|
| Autoradiography | 1 | 1984 | 730 | 0.010 |
Why?
|
| Mast Cells | 1 | 2010 | 1390 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2013 | 3527 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 728 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1983 | 213 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1983 | 112 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6238 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2684 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3711 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2392 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2005 | 4902 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 2003 | 73 | 0.010 |
Why?
|
| Audiometry | 1 | 2003 | 253 | 0.010 |
Why?
|
| Data Collection | 1 | 2012 | 3315 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1990 | 1141 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1983 | 343 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2003 | 101 | 0.010 |
Why?
|
| Vocalization, Animal | 1 | 2003 | 93 | 0.010 |
Why?
|
| Anesthesia | 1 | 2013 | 1584 | 0.010 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 143 | 0.010 |
Why?
|
| Psychometrics | 1 | 2012 | 3051 | 0.010 |
Why?
|
| Fatal Outcome | 2 | 1997 | 1832 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2003 | 165 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1414 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1984 | 416 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1996 | 8950 | 0.010 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1982 | 14 | 0.010 |
Why?
|
| Malonates | 1 | 1982 | 43 | 0.010 |
Why?
|
| Vertigo | 1 | 2003 | 202 | 0.010 |
Why?
|
| Candida | 1 | 2003 | 173 | 0.010 |
Why?
|
| Radiography | 2 | 1993 | 6965 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4350 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1992 | 1809 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9335 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2005 | 558 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1984 | 820 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2693 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 456 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2935 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5397 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2003 | 354 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4082 | 0.010 |
Why?
|
| Lac Operon | 1 | 2001 | 237 | 0.010 |
Why?
|
| United States | 3 | 2017 | 72448 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5961 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.010 |
Why?
|
| Dizziness | 1 | 2004 | 257 | 0.010 |
Why?
|
| Gene Order | 1 | 2001 | 169 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1982 | 131 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1985 | 344 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 2001 | 176 | 0.010 |
Why?
|
| Patient Selection | 1 | 2013 | 4279 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5745 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2012 | 1528 | 0.010 |
Why?
|
| Hypotension | 1 | 2006 | 883 | 0.010 |
Why?
|
| Canada | 1 | 2006 | 2126 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2696 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 1433 | 0.010 |
Why?
|
| Eye Movements | 1 | 2003 | 508 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 622 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9497 | 0.010 |
Why?
|
| Iron | 1 | 2008 | 1786 | 0.010 |
Why?
|
| Teratoma | 1 | 1983 | 403 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4122 | 0.010 |
Why?
|
| Binding Sites | 2 | 1999 | 6048 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2192 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2009 | 2092 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2015 | 6189 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2009 | 2314 | 0.010 |
Why?
|
| Accidents | 1 | 2000 | 166 | 0.010 |
Why?
|
| Retinoids | 1 | 1999 | 98 | 0.010 |
Why?
|
| Postural Balance | 1 | 2003 | 617 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 11152 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1900 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 701 | 0.010 |
Why?
|
| Septins | 1 | 1999 | 49 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12159 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1998 | 51 | 0.010 |
Why?
|
| Osteoporosis | 1 | 1988 | 1601 | 0.010 |
Why?
|
| Peptides | 2 | 2002 | 4354 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 558 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2010 | 3599 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 94 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 553 | 0.010 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1997 | 33 | 0.010 |
Why?
|
| Cattle | 1 | 1983 | 3847 | 0.010 |
Why?
|
| Titrimetry | 1 | 1997 | 35 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 315 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 3763 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1998 | 313 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3602 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2001 | 624 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6218 | 0.010 |
Why?
|
| Acidosis, Lactic | 1 | 1998 | 145 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2001 | 3164 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2003 | 1016 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1996 | 25 | 0.010 |
Why?
|
| Fetal Death | 1 | 1998 | 434 | 0.010 |
Why?
|
| RNA Helicases | 1 | 1997 | 146 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 6377 | 0.010 |
Why?
|
| Colorimetry | 1 | 1997 | 153 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 1007 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2001 | 697 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1997 | 199 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 1612 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1763 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1543 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 308 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1997 | 517 | 0.010 |
Why?
|
| Genistein | 1 | 1995 | 86 | 0.010 |
Why?
|
| Asparagine | 1 | 1995 | 119 | 0.010 |
Why?
|
| Chromans | 1 | 1995 | 117 | 0.010 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1995 | 8 | 0.010 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1997 | 207 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1995 | 122 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 3075 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1995 | 260 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2003 | 2943 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 422 | 0.010 |
Why?
|
| Isoflavones | 1 | 1995 | 136 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1997 | 499 | 0.010 |
Why?
|
| Neck | 1 | 1999 | 731 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2262 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 2421 | 0.010 |
Why?
|
| Leg | 1 | 1999 | 1091 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4000 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10442 | 0.010 |
Why?
|
| California | 1 | 1998 | 1416 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2012 | 3205 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2003 | 2058 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11481 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5508 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1998 | 865 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 3825 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 9994 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 818 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1992 | 151 | 0.010 |
Why?
|
| Cysteine | 1 | 1997 | 895 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 418 | 0.010 |
Why?
|
| Body Burden | 1 | 1992 | 158 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2001 | 2029 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8311 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6216 | 0.010 |
Why?
|
| Serine | 1 | 1995 | 831 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1995 | 459 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1995 | 13262 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 2222 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1997 | 1797 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1997 | 702 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1744 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 6831 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1998 | 1817 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5201 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2104 | 0.010 |
Why?
|
| Skin | 2 | 1999 | 4466 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1997 | 888 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 1617 | 0.010 |
Why?
|
| Phenols | 1 | 1992 | 514 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1988 | 114 | 0.000 |
Why?
|
| Recurrence | 1 | 2001 | 8483 | 0.000 |
Why?
|
| Elastin | 1 | 1990 | 301 | 0.000 |
Why?
|
| Muscles | 1 | 1993 | 1581 | 0.000 |
Why?
|
| Estradiol | 1 | 1995 | 1932 | 0.000 |
Why?
|
| Cartilage, Articular | 1 | 1993 | 1091 | 0.000 |
Why?
|
| Respiration | 1 | 1992 | 1654 | 0.000 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 1985 | 7 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1995 | 3380 | 0.000 |
Why?
|
| Glucosyltransferases | 1 | 1985 | 96 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1997 | 1951 | 0.000 |
Why?
|
| Myocardium | 1 | 1997 | 4700 | 0.000 |
Why?
|
| Metallothionein | 1 | 1983 | 61 | 0.000 |
Why?
|
| Phenytoin | 1 | 1984 | 188 | 0.000 |
Why?
|
| Galactosyltransferases | 1 | 1985 | 276 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3802 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2299 | 0.000 |
Why?
|
| Malonyl Coenzyme A | 1 | 1982 | 19 | 0.000 |
Why?
|
| Occipital Bone | 1 | 1982 | 55 | 0.000 |
Why?
|
| Acyl Coenzyme A | 1 | 1982 | 57 | 0.000 |
Why?
|
| Urinary Bladder Diseases | 1 | 1982 | 169 | 0.000 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1982 | 352 | 0.000 |
Why?
|
| Diverticulum | 1 | 1982 | 137 | 0.000 |
Why?
|
| Mannose | 1 | 1980 | 121 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9185 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1980 | 242 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1980 | 348 | 0.000 |
Why?
|
| Culture Media | 1 | 1980 | 900 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1995 | 9278 | 0.000 |
Why?
|
| Joint Instability | 1 | 1982 | 795 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1980 | 5132 | 0.000 |
Why?
|